secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001437749-24-000821
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Laboratories appoints Mark Capone to Board of Directors
------------------------------------------------------------

- Board expanded from 6 to 7 members; Capone appointed effective Jan 5, 2024.
- Capone most recently served as CEO/President of Myriad Genetics; also 17 yrs at Eli Lilly.
- Appointed to Audit Committee, replacing Shiraz Ladiwala.
- Capone determined independent under Nasdaq and SEC rules.
- No related party transactions with Mesa reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774924000821/0001437749-24-000821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774924000821/mlab20240103_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-000821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer